Significance of EGFR/HER2 Expression and PIK3CA Mutations in Giant Cell Tumour of Bone Development

Table 2

Correlations between Her2, EGFR, RANKL, and Her2/EGFR expression with recurrence.

	Parameter	With recurrence	Without recurrence	Recurrence rate	value
Expression HER2	++	4	2	66,66%
	+++	14	12	53,84%
Expression EGFR	+/++	6	13	31,57%
	+++	9	4	69,23%
Expression RANKL	+/++	8	15	34,78%
	+++	7	2	77,77%
Over EGFR/Her2	Negative	6	13	31,57%
	Positive	9	4	69,23%

Significantly different by the chi-squared test.